(Q43628877)

25 November 2017

title

Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway (English)

1 reference

ubiquitin-proteasome system

25 November 2017

main subject

0 references

author name string

J E Mullally

1

1 reference

25 November 2017

P J Moos

2

1 reference

25 November 2017

K Edes

3

1 reference

25 November 2017

F A Fitzpatrick

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

4 June 2001

1 reference

Journal of Biological Chemistry

25 November 2017

published in

1 reference

25 November 2017

volume

276

1 reference

25 November 2017

issue

32

1 reference

25 November 2017

page(s)

30366-30373

1 reference

Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Ubiquitin-dependent protein degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Suppression of human colorectal carcinoma cell growth by wild-type p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Basic Medical Research Award. The ubiquitin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Regulation of transcription factors by protein degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Regulation of p53 stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to delta 7-prostaglandin A1 and delta 12-prostaglandin J2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Predicting response to cancer chemotherapy: the role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

Activation of the Cell Death Program by Nitric Oxide Involves Inhibition of the Proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M102198200

21 January 2018

Identifiers

DOI

10.1074/JBC.M102198200

1 reference

25 November 2017

1 reference